Therapy response monitoring in blood plasma from esophageal adenocarcinoma patients using cell-free DNA methylation profiling
Abstract Esophageal adenocarcinoma (EAC) is an aggressive cancer characterized by a high risk of relapse post-surgery.Current follow-up methods (serum carcinoembryonic antigen detection and PET-CT) lack sensitivity and reliability, necessitating read more a novel approach.Analyzing cell-free DNA (cfDNA) from blood plasma emerges as a promising aven